bf/NASDAQ:ADTX_icon.jpeg

NASDAQ:ADTX

Aditxt, Inc. Common Stock

  • Stock

2.15

−2.71%

1.12

USD last updated 15/08 01:35:00

Last Close

1.03

14/08 21:12

Market Cap

5.23M

Beta: 1.57

Volume Today

72.38K

Avg: 615.10K

PE Ratio

−0.02

PFCF: −0.33

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplant...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1000-800-600-400-2002020-06-302021-08-122023-03-132024-03-192024-11-12

    Revenue (Estimate*)

    100K200K300K400K2020-06-302021-08-122023-03-132024-03-192024-11-12

    *Estimate based on analyst consensus